查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
2030 年北美痤瘡藥物市場預測 - 區域分析 - 按治療類別、配方、類型、痤瘡類型和配銷通路
市場調查報告書
商品編碼
1567795

2030 年北美痤瘡藥物市場預測 - 區域分析 - 按治療類別、配方、類型、痤瘡類型和配銷通路

North America Acne Medication Market Forecast to 2030 - Regional Analysis - by Therapeutic Class, Formulation, Type, Acne Type, and Distribution Channel
出版日期: | 出版商: The Insight Partners | 英文 121 Pages | 訂單完成後即時交付

價格

2022年北美痤瘡藥物市值為33.625億美元，預計到2030年將達到47.9401億美元；預計 2023 年至 2030 年複合年成長率為 4.6%。

對有機和自然療法的需求激增推動了北美痤瘡藥物市場

隨著人們越來越意識到傳統護膚產品中使用的合成成分和化學品的潛在有害影響，世界各地對被認為更安全、更溫和、更環保的天然和有機替代品的需求正在增加。消費者擴大尋求不含刺激性化學物質、人造香料和潛在刺激性物質的產品，選擇利用植物成分、植物萃取物、精油和其他以其護膚功效而聞名的天然化合物的配方。為了應對這一趨勢，許多護膚品牌和製造商正在開發各種天然有機痤瘡治療產品，以滿足注重健康的消費者的需求。這些產品通常含有茶樹油、金縷梅、蘆薈、綠茶萃取物和水楊酸等天然成分，提供更全面、更永續的痤瘡治療方法，同時又不影響功效。 2022年7月，有機護膚企業MADARA推出了兩款新型天然日常護膚產品－微生物平衡保濕霜和不乾燥潔面乳。該公司聲稱，這些產品是融合科學和自然而開發的，專門為不同膚色、容易長粉刺的人提供溫和的治療。這兩款產品均採用天然、有機和純素成分製成——北方杜松幹細胞、發酵多醣、地衣和馬黛茶萃取物——專門針對瑕疵，保持皮膚不受傷害。成人和青少年都可以使用該產品。因此，對天然和有機痤瘡治療方案的日益偏好預計將在未來幾年繼續塑造北美痤瘡藥物市場的未來。

日益嚴格的監管審查以及與行業標準相關的併發症也推動了向天然和有機痤瘡治療方案的轉變。監管機構強調成分透明度、安全性和永續性，促使公司重新制定產品配方，以滿足消費者對更清潔、更環保的護膚解決方案不斷變化的偏好。因此，隨著越來越多的消費者在日常護膚中優先考慮天然成分和環保配方，預計北美痤瘡藥物市場在未來幾年將經歷新的成長趨勢。

北美痤瘡藥物市場概況

北美的痤瘡藥物市場分為美國、加拿大和墨西哥。到 2022 年，美國將佔據北美最大的痤瘡藥物市場佔有率。根據美國皮膚病學會的數據，痤瘡是美國最常見的疾病，每年有多達 5000 萬美國人患有痤瘡，使其成為全國最常見的皮膚病。由於美國人痤瘡發病率的增加以及隨後各種創新痤瘡藥物的推出，預計該國的痤瘡藥物市場將會擴大。

北美痤瘡藥物市場收入及 2030 年預測（百萬美元）

北美痤瘡藥物市場細分

北美痤瘡藥物市場根據治療類別、配方、類型、痤瘡類型、配銷通路和國家進行細分。

根據治療類別，北美痤瘡藥物市場分為類維生素A、過氧化苯甲醯、抗生素、水楊酸等。 2022 年，類視黃醇細分市場佔據最大佔有率。

從劑型來看，北美痤瘡藥物市場分為外用藥物和口服藥物。 2022 年，外用藥物領域佔據更大的佔有率。

按類型分類，北美痤瘡藥物市場分為處方藥和非處方藥。 2022 年，處方藥細分市場將佔據更大的佔有率。

根據痤瘡類型，北美痤瘡藥物市場分為非發炎性痤瘡和發炎性痤瘡。 2022 年，發炎性痤瘡部分佔據了更大的佔有率。

就配銷通路而言，北美痤瘡藥物市場分為藥局和藥局、零售店和電子商務。 2022 年，藥局和藥局細分市場佔據最大佔有率。

根據國家/地區，北美痤瘡藥物市場分為美國、加拿大和墨西哥。 2022 年，美國主導北美痤瘡藥物市場。

Sun Pharmaceutical Industries Ltd、Teva Pharmaceutical Industries Ltd、Almirall SA、強生公司、Bausch Health Companies Inc、Centro Internacional de Cosmiatria SA de CV、Galderma SA、輝瑞公司、GSK Plc、Viatris Inc、Somar Sapi De CV 和 Italmex SA為北美公司、GSK Plc、Viatris Inc、Somar Sapi De CV 和 Italmex SA痤瘡藥物市場上的一些領先公司。

目錄

第 1 章：簡介

第 2 章：執行摘要

  • 主要見解

第 3 章：研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第 4 章：北美痤瘡藥物市場格局

  • PEST分析
  • 外用和口服藥物的定價分析
  • 接受痤瘡治療的患者群

第 5 章：北美痤瘡藥物市場 - 主要市場動態

  • 主要市場促進因素
    • 嚴重痤瘡的盛行率不斷增加
    • 新藥上市
  • 主要市場限制
    • 與痤瘡藥物相關的副作用
  • 主要市場機會
    • 基於尖端技術和數據驅動策略的個人化治療方案
  • 未來趨勢
    • 對有機和自然療法的需求激增
  • 促進因素和限制的影響：

第 6 章：痤瘡藥物市場 - 北美市場分析

第 7 章：北美痤瘡藥物市場分析 - 按治療類別

  • 類維生素A
  • 過氧化苯甲醯
  • 抗生素
  • 水楊酸
  • 其他

第 8 章：北美痤瘡藥物市場分析 - 按配方

  • 外用藥物
  • 口服藥物

第 9 章：北美痤瘡藥物市場分析 - 按類型

  • 處方藥
  • 非處方藥

第 10 章：北美痤瘡藥物市場分析 - 按痤瘡類型

  • 非發炎性痤瘡
  • 發炎性痤瘡

第 11 章：北美痤瘡藥物市場分析 - 按配銷通路

  • 藥局和藥局
  • 零售店
  • 電子商務

第 12 章：北美痤瘡藥物市場 - 國家分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥

第 13 章：痤瘡藥物市場-產業格局

  • 概述
  • 痤瘡藥物市場的成長策略
  • 有機成長策略
    • 概述
  • 無機成長策略
    • 概述
  • Farmapiel 提供的產品與其他公司痤瘡產品的比較

第 14 章：公司簡介

  • Teva Pharmaceutical Industries Ltd
  • Almirall SA
  • Johnson & Johnson
  • Sun Pharmaceutical Industries Ltd
  • Bausch Health Companies Inc
  • Centro Internacional de Cosmiatria SA de CV
  • Galderma SA
  • Pfizer Inc
  • GSK Plc
  • Viatris Inc
  • Somar Sapi De CV
  • Italmex SA

第 15 章：附錄

Product Code: BMIRE00030656

The North America acne medication market was valued at US$ 3,362.50 million in 2022 and is expected to reach US$ 4,794.01 million by 2030; it is estimated to register at a CAGR of 4.6% from 2023 to 2030.

Upsurge in Need for Organic and Natural Treatments Fuels North America Acne Medication Market

As people are becoming more conscious of the potentially harmful effects of synthetic ingredients and chemicals used in traditional skincare products, the demand for natural and organic alternatives that are deemed to be safer, gentler, and more environmentally friendly is on the rise across the world. Consumers are increasingly seeking products free from harsh chemicals, artificial fragrances, and potentially irritating substances, opting for formulations that harness the power of plant-based ingredients, botanical extracts, essential oils, and other natural compounds known for their skincare benefits. In response to this trend, many skincare brands and manufacturers are developing a wide range of natural and organic acne treatment products that cater to the needs of health-conscious consumers. These products often feature ingredients such as tea tree oil, witch hazel, aloe vera, green tea extract, and salicylic acid derived from natural sources, offering a more holistic and sustainable approach to treating acne without compromising efficacy. In July 2022, MADARA, an organic skincare business, introduced two new and natural everyday skincare products-a microbiome-balancing moisturizer and a non-drying face cleanser. The company claims that these products were developed by blending science and nature, and were specifically formulated to offer gentle treatment for people of different complexions, who are prone to acne. Both products are made with natural, organic, and vegan ingredients-Northern Juniper Stem Cells, fermented polysaccharides, and lichen and Mate tea extracts-which deal specifically with imperfections, keeping the skin unharmed. Adults and teenagers can both utilize this product. Thus, the increasing preference for natural and organic acne treatment options is expected to continue shaping the future of the North America acne medication market in the coming years.

The shift toward natural and organic acne treatment options is also driven by the increasing stringency of regulatory scrutiny and complications associated with industry standards. Regulatory agencies emphasize ingredient transparency, safety, and sustainability, prompting companies to reformulate their products to meet evolving consumer preferences for cleaner and greener skincare solutions. Thus, as more consumers prioritize natural ingredients and eco-friendly formulations in their skincare routines, the North America acne medication market is expected to experience new growth trends in the coming years.

North America Acne Medication Market Overview

The acne medication market in North America is segmented into the US, Canada, and Mexico. The US held the largest North American acne medication market share in 2022. Acne is a skin condition brought on by debris, oil, sebum, and dead skin cells clogging hair follicles. According to the American Academy of Dermatology, acne is the most prevalent illness in the US, up to 50 million Americans suffer from acne each year, making it the most common skin ailment in the country. The acne medication market in this country is projected to expand due to the increased incidence of acne in Americans and the subsequent launch of various innovative acne medications.

North America Acne Medication Market Revenue and Forecast to 2030 (US$ Million)

North America Acne Medication Market Segmentation

The North America acne medication market is segmented based on therapeutic class, formulation, type, acne type, and distribution channel, and country.

Based on therapeutic class, the North America acne medication market is segmented into retinoids, benzoyl peroxide, antibiotics, salicylic acid, and others. The retinoids segment held the largest share in 2022.

In terms of formulation, the North America acne medication market is bifurcated into topical medication and oral medication. The topical medication segment held a larger largest share in 2022.

By type, the North America acne medication market is bifurcated into prescription medicine and over-the-counter medicine. The prescription medicine segment held a larger largest share in 2022.

Based on acne type, the North America acne medication market is bifurcated into non-inflammatory acne and inflammatory acne. The inflammatory acne segment held a larger share in 2022.

In terms of distribution channel, the North America acne medication market is segmented into pharmacies and drug stores, retail stores, and e-commerce. The pharmacies and drug stores segment held the largest share in 2022.

Based on country, the North America acne medication market is categorized into US, Canada, and Mexico. The US dominated the North America acne medication market in 2022.

Sun Pharmaceutical Industries Ltd, Teva Pharmaceutical Industries Ltd, Almirall SA, Johnson & Johnson, Bausch Health Companies Inc, Centro Internacional de Cosmiatria SA de CV, Galderma SA, Pfizer Inc, GSK Plc, Viatris Inc, Somar Sapi De CV, and Italmex SA are some of the leading companies operating in the North America acne medication market.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. North America Acne Medication Market Landscape

  • 4.1 PEST Analysis
  • 4.2 Pricing Analysis of Topical and Oral Medication
  • 4.3 Patient Population Undergoing Acne Treatment

5. North America Acne Medication Market - Key Market Dynamics

  • 5.1 Key Market Drivers
    • 5.1.1 Increasing Prevalence of Severe Acne
    • 5.1.2 Launch of Novel Drugs
  • 5.2 Key Market Restraints
    • 5.2.1 Side Effects Associated with Acne Medication
  • 5.3 Key Market Opportunities
    • 5.3.1 Individualized Treatment Programs Based on Cutting-Edge Technologies and Data-Driven Strategies
  • 5.4 Future Trends
    • 5.4.1 Upsurge in Need for Organic and Natural Treatments
  • 5.5 Impact of Drivers and Restraints:

6. Acne Medication Market - North America Market Analysis

7. North America Acne Medication Market Analysis - by Therapeutic Class

  • 7.1 Retinoids
    • 7.1.1 Overview
    • 7.1.2 Retinoids: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.2 Benzoyl Peroxide
    • 7.2.1 Overview
    • 7.2.2 Benzoyl Peroxide: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.3 Antibiotics
    • 7.3.1 Overview
    • 7.3.2 Antibiotics: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 Salicylic Acid
    • 7.4.1 Overview
    • 7.4.2 Salicylic Acid: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.5 Others
    • 7.5.1 Overview
    • 7.5.2 Others: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

8. North America Acne Medication Market Analysis - by Formulation

  • 8.1 Topical Medication
    • 8.1.1 Overview
    • 8.1.2 Topical Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.2 Oral Medication
    • 8.2.1 Overview
    • 8.2.2 Oral Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

9. North America Acne Medication Market Analysis - by Type

  • 9.1 Prescription Medicine
    • 9.1.1 Overview
    • 9.1.2 Prescription Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 9.2 Over-the-Counter Medicine
    • 9.2.1 Overview
    • 9.2.2 Over-the-Counter Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

10. North America Acne Medication Market Analysis - by Acne Type

  • 10.1 Non-Inflammatory Acne
    • 10.1.1 Overview
    • 10.1.2 Non-Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 10.2 Inflammatory Acne
    • 10.2.1 Overview
    • 10.2.2 Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

11. North America Acne Medication Market Analysis - by Distribution Channel

  • 11.1 Pharmacies and Drug Stores
    • 11.1.1 Overview
    • 11.1.2 Pharmacies and Drug Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.2 Retail Stores
    • 11.2.1 Overview
    • 11.2.2 Retail Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • 11.3 E-Commerce
    • 11.3.1 Overview
    • 11.3.2 E-Commerce: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)

12. North America Acne Medication Market - Country Analysis

  • 12.1 North America
    • 12.1.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.1 North America: Acne Medication Market - Revenue and Forecast Analysis - by Country
      • 12.1.1.2 US
      • 12.1.1.3 US: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.3.1 US: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.3.2 US: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.3.3 US: Acne Medication Market Breakdown, by Type
        • 12.1.1.3.4 US: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.3.5 US: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.4 Canada
      • 12.1.1.5 Canada: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.5.1 Canada: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.5.2 Canada: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.5.3 Canada: Acne Medication Market Breakdown, by Type
        • 12.1.1.5.4 Canada: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.5.5 Canada: Acne Medication Market Breakdown, by Distribution Channel
      • 12.1.1.6 Mexico
      • 12.1.1.7 Mexico: Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
        • 12.1.1.7.1 Mexico: Acne Medication Market Breakdown, by Therapeutic Class
        • 12.1.1.7.2 Mexico: Acne Medication Market Breakdown, by Formulation
        • 12.1.1.7.3 Mexico: Acne Medication Market Breakdown, by Type
        • 12.1.1.7.4 Mexico: Acne Medication Market Breakdown, by Acne Type
        • 12.1.1.7.5 Mexico: Acne Medication Market Breakdown, by Distribution Channel

13. Acne Medication Market- Industry Landscape

  • 13.1 Overview
  • 13.2 Growth Strategies in Acne Medication Market
  • 13.3 Organic Growth Strategies
    • 13.3.1 Overview
  • 13.4 Inorganic Growth Strategies
    • 13.4.1 Overview
  • 13.5 Product Offered by Farmapiel vs Other Companies Acne Products

14. Company Profiles

  • 14.1 Teva Pharmaceutical Industries Ltd
    • 14.1.1 Key Facts
    • 14.1.2 Business Description
    • 14.1.3 Products and Services
    • 14.1.4 Financial Overview
    • 14.1.5 SWOT Analysis
    • 14.1.6 Key Developments
  • 14.2 Almirall SA
    • 14.2.1 Key Facts
    • 14.2.2 Business Description
    • 14.2.3 Products and Services
    • 14.2.4 Financial Overview
    • 14.2.5 SWOT Analysis
    • 14.2.6 Key Developments
  • 14.3 Johnson & Johnson
    • 14.3.1 Key Facts
    • 14.3.2 Business Description
    • 14.3.3 Products and Services
    • 14.3.4 Financial Overview
    • 14.3.5 SWOT Analysis
    • 14.3.6 Key Developments
  • 14.4 Sun Pharmaceutical Industries Ltd
    • 14.4.1 Key Facts
    • 14.4.2 Business Description
    • 14.4.3 Products and Services
    • 14.4.4 Financial Overview
    • 14.4.5 SWOT Analysis
    • 14.4.6 Key Developments
  • 14.5 Bausch Health Companies Inc
    • 14.5.1 Key Facts
    • 14.5.2 Business Description
    • 14.5.3 Products and Services
    • 14.5.4 Financial Overview
    • 14.5.5 SWOT Analysis
    • 14.5.6 Key Developments
  • 14.6 Centro Internacional de Cosmiatria SA de CV
    • 14.6.1 Key Facts
    • 14.6.2 Business Description
    • 14.6.3 Products and Services
    • 14.6.4 Financial Overview
    • 14.6.5 SWOT Analysis
    • 14.6.6 Key Developments
  • 14.7 Galderma SA
    • 14.7.1 Key Facts
    • 14.7.2 Business Description
    • 14.7.3 Products and Services
    • 14.7.4 Financial Overview
    • 14.7.5 SWOT Analysis
    • 14.7.6 Key Developments
  • 14.8 Pfizer Inc
    • 14.8.1 Key Facts
    • 14.8.2 Business Description
    • 14.8.3 Products and Services
    • 14.8.4 Financial Overview
    • 14.8.5 SWOT Analysis
    • 14.8.6 Key Developments
  • 14.9 GSK Plc
    • 14.9.1 Key Facts
    • 14.9.2 Business Description
    • 14.9.3 Products and Services
    • 14.9.4 Financial Overview
    • 14.9.5 SWOT Analysis
    • 14.9.6 Key Developments
  • 14.10 Viatris Inc
    • 14.10.1 Key Facts
    • 14.10.2 Business Description
    • 14.10.3 Products and Services
    • 14.10.4 Financial Overview
    • 14.10.5 SWOT Analysis
    • 14.10.6 Key Developments
  • 14.11 Somar Sapi De CV
    • 14.11.1 Key Facts
    • 14.11.2 Business Description
    • 14.11.3 Products and Services
    • 14.11.4 Financial Overview
    • 14.11.5 SWOT Analysis
    • 14.11.6 Key Developments
  • 14.12 Italmex SA
    • 14.12.1 Key Facts
    • 14.12.2 Business Description
    • 14.12.3 Products and Services
    • 14.12.4 Financial Overview
    • 14.12.5 SWOT Analysis
    • 14.12.6 Key Developments

15. Appendix

  • 15.1 About The Insight Partners
  • 15.2 Glossary of Terms

List Of Tables

  • Table 1. North America Acne Medication Market Segmentation
  • Table 2. Topical Medication
  • Table 3. Oral Medication
  • Table 4. Patient Population undergoing Acne Treatment from 2020-2023
  • Table 5. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Therapeutic Class
  • Table 6. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Formulation
  • Table 7. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Type
  • Table 8. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Acne Type
  • Table 9. North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million) - by Distribution Channel
  • Table 10. North America: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Country
  • Table 11. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 12. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 13. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 14. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 15. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 16. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 17. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 18. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 19. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 20. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 21. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Therapeutic Class
  • Table 22. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Formulation
  • Table 23. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Type
  • Table 24. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Acne Type
  • Table 25. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million) - by Distribution Channel
  • Table 26. Recent Organic Growth Strategies in Acne Medication Market
  • Table 27. Recent Inorganic Growth Strategies in the Acne Medication Market
  • Table 28. Glossary of Terms, Acne Medication Market

List Of Figures

  • Figure 1. North America Acne Medication Market Segmentation, by Country
  • Figure 2. PEST Analysis
  • Figure 3. North America Acne Medication Market - Key Market Dynamics
  • Figure 4. Impact Analysis of Drivers and Restraints
  • Figure 5. North America Acne Medication Market Revenue (US$ Million), 2020-2030
  • Figure 6. North America Acne Medication Market Share (%) - by Therapeutic Class (2022 and 2030)
  • Figure 7. Retinoids: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 8. Benzoyl Peroxide: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 9. Antibiotics: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 10. Salicylic Acid: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 11. Others: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 12. North America Acne Medication Market Share (%) - by Formulation (2022 and 2030)
  • Figure 13. Topical Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Oral Medication: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. North America Acne Medication Market Share (%) - by Type (2022 and 2030)
  • Figure 16. Prescription Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. Over-the-Counter Medicine: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. North America Acne Medication Market Share (%) - by Acne Type (2022 and 2030)
  • Figure 19. Non-Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Inflammatory Acne: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 21. North America Acne Medication Market Share (%) - by Distribution Channel (2022 and 2030)
  • Figure 22. Pharmacies and Drug Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Retail Stores: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. E-Commerce: North America Acne Medication Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. North America: Acne Medication Market - Country, 2022 (US$ Million)
  • Figure 26. North America: Acne Medication Market Breakdown, by Key Countries, 2022 and 2030 (%)
  • Figure 27. US: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 28. Canada: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 29. Mexico: Acne Medication Market - Revenue and Forecast to 2030(US$ Million)
  • Figure 30. Growth Strategies in Acne Medication Market